Skip to main content
FinSpry Logo
FinSpry
TRVI logo
TRVI
(NASDAQ)
Trevi Therapeutics, Inc.
$11.94-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Trevi Therapeutics, Inc. (TRVI) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Trevi Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Strong Buy
Based on 5 unique analysts
(8 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$21.20
↑ 77.55% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest TRVI Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Debanjana Chatterjee
Jones Trading
Strong BuyMaintains
$25.00 → $24.00
Jason Kolbert
D Boral Capital
Strong BuyMaintains
$19.00 → $19.00
Serge Belanger
Needham
Strong BuyMaintains
$22.00 → $24.00
Judah Frommer
Morgan Stanley
BuyMaintains
$19.00 → $18.00
Jason Kolbert
D Boral Capital
Strong BuyMaintains
$19.00 → $19.00
Brandon Folkes
HC Wainwright
Strong BuyReiterates
$21.00 → $21.00
Brandon Folkes
HC Wainwright
Strong BuyReiterates
$21.00 → $21.00
Jason Kolbert
D Boral Capital
Strong BuyMaintains
$19.00 → $19.00

Frequently Asked Questions

What is the analyst consensus rating for TRVI?

The analyst consensus rating for TRVI is "Strong Buy" based on 5 analyst recommendations.

What is the average price target for TRVI?

The average 12-month price target for TRVI is $21.20, representing an upside of 77.6% from the current price of $11.94.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.